Giuseppe Ciaramella
Vermögen: 8 Mio $ am 31.05.2026
Vermögen: 8 Mio $ am 31.05.2026
Derzeit ist Giuseppe Ciaramella President & Chief Scientific Officer bei Beam Therapeutics, Inc. Er ist außerdem Mitglied der Infectious Diseases Society of America und Mitglied der American Society of Gene Therapy. In der Vergangenheit hatte Dr. Ciaramella die Position des Chief Scientific Officer-Infectious Diseases bei Moderna, Inc. inne, Head-Biotherapeutics, Antivirals & Lead Discovery bei Pfizer Group Ltd. und Vice President & Head-Collaborative Research bei Boehringer Ingelheim Corp. Giuseppe Ciaramella erhielt einen Doktortitel vom University College London.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 17.06.2026 | 253’911 ( 0.25% ) | 8 Mio $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| BEAM THERAPEUTICS INC. | Präsident | 24.01.2020 |
Infectious Diseases Society of America
Infectious Diseases Society of America Miscellaneous Commercial ServicesCommercial Services Operates as a medical association representing physicians, scientists, and other healthcare professionals | Corporate Officer/Principal | - |
American Society of Gene Therapy | Corporate Officer/Principal | - |
| Unternehmen | Position | Ende |
|---|---|---|
Orbital Therapeutics, Inc.
Orbital Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops RNA-based medicines | Gründer | 03.09.2024 |
| MODERNA, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.02.2018 |
AstraZeneca LP
AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE. | Direktor/Vorstandsmitglied | 01.01.2014 |
Boehringer Ingelheim Corp.
Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets health care products | Corporate Officer/Principal | 01.01.2011 |
Pfizer Group Ltd.
Pfizer Group Ltd. Pharmaceuticals: MajorHealth Technology Manufacturers and sells pharmaceuticals, animal health products and health care products | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 9 |
|---|---|
Pfizer Group Ltd.
Pfizer Group Ltd. Pharmaceuticals: MajorHealth Technology Manufacturers and sells pharmaceuticals, animal health products and health care products | Health Technology |
University College London
University College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boehringer Ingelheim Corp.
Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets health care products | Health Technology |
Infectious Diseases Society of America
Infectious Diseases Society of America Miscellaneous Commercial ServicesCommercial Services Operates as a medical association representing physicians, scientists, and other healthcare professionals | Commercial Services |
American Society of Gene Therapy | |
AstraZeneca LP
AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE. | Health Technology |
Beam Therapeutics, Inc.
Beam Therapeutics, Inc. BiotechnologyHealth Technology Operate as a biotechnology company that develops precision genetic medicines, gene editing and delivery technologies | Health Technology |
Moderna, Inc.
Moderna, Inc. BiotechnologyHealth Technology Researches, develops, manufactures and commercializes mRNA-based respiratory & other virus vaccines, oncology and rare disease therapeutics | Health Technology |
Orbital Therapeutics, Inc.
Orbital Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops RNA-based medicines | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen